» Articles » PMID: 35265260

Rhodiola Rosea: A Therapeutic Candidate on Cardiovascular Diseases

Overview
Publisher Wiley
Date 2022 Mar 10
PMID 35265260
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases, also known as circulatory diseases, are diseases of the heart and blood vessels, and its etiology is hyperlipidemia, thick blood, atherosclerosis, and hypertension. Due to its high prevalence, disability, and mortality, it seriously threatens human health. According to reports, the incidence of cardiovascular disease is still on the rise. Rhodiola rosea is a kind of traditional Chinese medicine, which has the effects of antimyocardial ischemia-reperfusion injury, lowering blood fat, antithrombosis, and antiarrhythmia. Rhodiola rosea has various chemical components, and different chemical elements have the same pharmacological effects and medicinal values for various cardiovascular diseases. This article reviews the research on the pharmacological effects of Rhodiola rosea on cardiovascular diseases and provides references for the clinical treatment of cardiovascular diseases.

Citing Articles

Salidroside: An Overview of Its Promising Potential and Diverse Applications.

Liang K, Ma S, Luo K, Wang R, Xiao C, Zhang X Pharmaceuticals (Basel). 2025; 17(12.

PMID: 39770545 PMC: 11678419. DOI: 10.3390/ph17121703.


Silexan in anxiety, depression, and related disorders: pharmacological background and clinical data.

Kasper S, Eckert A Eur Arch Psychiatry Clin Neurosci. 2024; .

PMID: 39453446 DOI: 10.1007/s00406-024-01923-8.


Exploring the therapeutic potential of "Tianyu" medicine pair in rheumatoid arthritis: an integrated study combining LC-MS/MS, bioinformatics, network pharmacology, and experimental validation.

Tang L, Guo D, Jia D, Piao S, Fang C, Zhu Y Front Med (Lausanne). 2024; 11:1475239.

PMID: 39430588 PMC: 11488520. DOI: 10.3389/fmed.2024.1475239.


Salidroside rescues hypoxic cardiomyocytes by regulating the EGLN1/HIF‑1α pathway.

Zhang W, Liao Z, Xu C, Lin X Biomed Rep. 2024; 21(6):180.

PMID: 39387002 PMC: 11462497. DOI: 10.3892/br.2024.1868.


Exploring the anti‑oxidative mechanisms of in ameliorating myocardial fibrosis through network pharmacology and experiments.

Zhang L, Yin H, Xie Y, Zhang Y, Dong F, Wu K Mol Med Rep. 2024; 30(6).

PMID: 39370810 PMC: 11450433. DOI: 10.3892/mmr.2024.13338.


References
1.
Chen P, Liu J, Ruan H, Zhang M, Wu P, Yimei D . Protective effects of Salidroside on cardiac function in mice with myocardial infarction. Sci Rep. 2019; 9(1):18127. PMC: 6888872. DOI: 10.1038/s41598-019-54713-x. View

2.
Xu Y, Jiang H, Sun C, Adu-Frimpong M, Deng W, Yu J . Antioxidant and hepatoprotective effects of purified Rhodiola rosea polysaccharides. Int J Biol Macromol. 2018; 117:167-178. DOI: 10.1016/j.ijbiomac.2018.05.168. View

3.
Hsiao Y, Tsai Y, Huang Y, Liu S, Lin Y, Lo L . Rhodiola crenulata reduces ventricular arrhythmia through mitigating the activation of IL-17 and inhibiting the MAPK signaling pathway. Cardiovasc Drugs Ther. 2020; 35(5):889-900. DOI: 10.1007/s10557-020-07072-z. View

4.
Ali Z, Fronczek F, Khan I . Phenylalkanoids and monoterpene analogues from the roots of Rhodiola rosea. Planta Med. 2008; 74(2):178-81. DOI: 10.1055/s-2008-1034288. View

5.
Sun L, Fan H, Yang L, Shi L, Liu Y . Tyrosol prevents ischemia/reperfusion-induced cardiac injury in H9c2 cells: involvement of ROS, Hsp70, JNK and ERK, and apoptosis. Molecules. 2015; 20(3):3758-75. PMC: 6272375. DOI: 10.3390/molecules20033758. View